Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Author
Log in
Sign up
DR
Daisy Rohena
Author with expertise in Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
Achievements
This user has not unlocked any achievements yet.
Key Stats
Upvotes received:
0
Publications:
4
(0% Open Access)
Cited by:
0
h-index:
0
/
i10-index:
0
Reputation
Biology
< 1%
Chemistry
< 1%
Economics
< 1%
Show more
How is this calculated?
Overview
Publications
4
Peer Reviews
Comments
Grants
Publications
0
Generation of a Patient Derived T-Cell Prolymphocytic Leukemia Xenograft Model to Evaluate Pre-Clinical Treatment with Small Molecule Inhibitors
In Vivo
Claudia Kettlun
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
TP53 Gain-of-Function Mutants Display Unique Transcriptional Profiles in Chronic Lymphocytic Leukemia
Charmelle Williams
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Venetoclax As a Combination Partner with NAMPT Inhibitor Rpt-1G for T-ALL
John Sanchez
et al.
Nov 5, 2024
Biochemistry
Oncology
0
Paper
Biochemistry
Oncology
0
Save
0
Protein Degrader WH25244 Eliminates Venetoclax Resistance Factors: Mutant or Hyperphosphorylated BCL2, and BCL-XL
Daisy Rohena
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save